NCT05889377

Brief Summary

Post extraction alveolar bone resorption is one of the main challenges that face oral implantologists in their daily surgical practice (1). To palliate to post-extraction resorption, advanced bone grafting and regeneration techniques have been described (2). However, these procedures, although well documented and validated, still have relatively high complication rates and patient morbidity, in addition to the elevated cost and duration of treatment (3). Socket preservation is a very useful technique in order to counter post extraction resorption issues, therefore eliminating the need for future complicated and delicate regeneration procedures (4). Many biomaterials were proposed for socket preservation such as allografts and bovine hydroxyapatite (5). Recently autologous platelet concentrates such as Platelet Rich Fibrin PRF were described as a potential socket filler material (6). In the proposed protocol, fresh extraction sockets will be either grafted by a bovine bone substitute, a PRF plug or a mixture of both. Sockets will then be clinically and radiographically monitored over time to assess three-dimensional soft and hard tissue stability. Bone quality will be histologically examined at 6 months implant placement. A no graft group will serve as control. The results of this study may be of major importance since they could give an objective idea of the most efficient socket preservation technique, thus offering simple and secure oral rehabilitation solutions for both patient and practitioner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 3, 2021

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 11, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 5, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2024

Completed
Last Updated

May 16, 2025

Status Verified

May 1, 2023

Enrollment Period

3.1 years

First QC Date

May 11, 2023

Last Update Submit

May 13, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Hard tissue change by measuring bone profil retraction between 0,4 and 12 months using 3D slicer software

    Comparison of the bone profile change by CBCT dicom files superimposition at different time frame

    4 and 12 months

  • Soft tissue change by measuring gingival retraction between 0,4 and 12 months using 3D slicer sftware

    Comparison of the soft tissue profile change by STL files superimposition at different time frame

    4 and 12 months

Study Arms (4)

Bovine Bone

EXPERIMENTAL
Procedure: Socket preservation

Platelet Rich Fibrin

EXPERIMENTAL
Procedure: Socket preservation

Bovine Bone + PRF

EXPERIMENTAL
Procedure: Socket preservation

Control

NO INTERVENTION

Interventions

Socket preservation will be done after tooth extraction. For each group we will use a bone substitute.

Bovine BoneBovine Bone + PRFPlatelet Rich Fibrin

Eligibility Criteria

Age18 Years - 62 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients will require single tooth extraction and subsequent implant rehabilitation.
  • Patients over 18 years of age.
  • Patients willing to comply with the study requirements (signed consent form)
  • Good oral hygiene and no signs of active periodontal infection
  • No compromising medical status
  • \< 10 cigarettes smoking per day

You may not qualify if:

  • acute myocardial infarction within the last two months;
  • Uncontrolled coagulation disorders;
  • uncontrolled diabetes (HBA1c\> 7.5);
  • radiation therapy to the head \\ neck region in the last 24 months;
  • immunocompromised patients, HIV positive or receiving chemotherapy in the last five years;
  • past or present treatment with intravenous bisphosphonates;
  • psychological or psychiatric problems;
  • abuse of alcohol or drugs;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Joseph University

Beirut, Lebanon

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 11, 2023

First Posted

June 5, 2023

Study Start

November 3, 2021

Primary Completion

December 20, 2024

Study Completion

December 20, 2024

Last Updated

May 16, 2025

Record last verified: 2023-05

Locations